| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 11th June 2020 | Diane C. Young | 2,115 | Open or private purchase | $4.73 | $10,003.95 |
| 10th June 2020 | Sarah Cavanaugh | 1,050 | Open or private purchase | $4.83 | $5,071.50 |
| 9th June 2020 | James J Marino | 8,305 | Open or private purchase | $3.00 | $24,915.00 |
| 9th June 2020 | Anthony S Marucci | 15,000 | Open or private purchase | $3.06 | $45,900.00 |
| 9th June 2020 | Samuel Bates Martin | 9,750 | Open or private purchase | $3.05 | $29,737.50 |
| 9th June 2020 | Tibor Keler | 5,000 | Open or private purchase | $2.99 | $14,954.00 |
| 9th June 2020 | Margo Heath Chiozzi | 1,000 | Open or private purchase | $3.01 | $3,005.00 |
| 25th November 2019 | James J Marino | 150,000 | Open or private purchase | $0.20 | $30,000.00 |
| 25th September 2019 | James J Marino | 7,260 | Open or private purchase | $1.60 | $11,616.00 |
Celldex Therapeutics
Celldex Therapeutics, Inc. engages in the research, development, and commercialization of immunotherapies and other targeted biologics. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.
Ticker: CLDX
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 744218
Employees: 130
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
We weren't able to import Fundamental data from the SEC disclosure.
There were no Red Flags found
Fundamentals
We weren't able to import Fundamental data from the SEC disclosure.
News
Behind real estate’s surprise 2020 boom and what comes next
24th October 2020
US judge will not reverse decision on WeChat app store ban
23rd October 2020